bendamustine hydrochloride has been researched along with Carcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernhardt, G; Buschauer, A; Hacker, K; Huber, S; Huettner, JP; König, J | 1 |
Chow, KU; Hoelzer, D; Mitrou, PS; Rummel, MJ; Weidmann, E | 1 |
2 other study(ies) available for bendamustine hydrochloride and Carcinoma
Article | Year |
---|---|
Esters of Bendamustine Are by Far More Potent Cytotoxic Agents than the Parent Compound against Human Sarcoma and Carcinoma Cells.
Topics: Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Carcinoma; Cell Line, Tumor; Esters; HEK293 Cells; Humans; Organic Cation Transport Proteins; Organic Cation Transporter 1; Sarcoma | 2015 |
In vitro studies with bendamustine: enhanced activity in combination with rituximab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bendamustine Hydrochloride; Carcinoma; Complement System Proteins; Drug Synergism; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Nitrogen Mustard Compounds; Rituximab; Tumor Cells, Cultured | 2002 |